Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Insider Sells 11,731 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 11,731 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, December 31st. The stock was sold at an average price of $8.18, for a total transaction of $95,959.58. Following the completion of the sale, the insider directly owned 305,799 shares of the company’s stock, valued at $2,501,435.82. The trade was a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Aveanna Healthcare Trading Down 1.1%

Shares of AVAH traded down $0.09 during mid-day trading on Friday, hitting $8.08. The company had a trading volume of 2,526,966 shares, compared to its average volume of 1,076,101. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.67 and a 1-year high of $10.32. The business’s 50-day simple moving average is $8.92 and its 200-day simple moving average is $7.49. The stock has a market cap of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The company had revenue of $450.53 million for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. Sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have commented on AVAH shares. BMO Capital Markets assumed coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They set an “outperform” rating and a $11.00 price target for the company. UBS Group boosted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a report on Friday, November 7th. Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. William Blair assumed coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating on the stock. Finally, Truist Financial boosted their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $10.69.

Institutional Trading of Aveanna Healthcare

Institutional investors have recently added to or reduced their stakes in the stock. Dynamic Technology Lab Private Ltd grew its holdings in Aveanna Healthcare by 8.9% during the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after acquiring an additional 1,151 shares in the last quarter. Barclays PLC lifted its position in shares of Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after purchasing an additional 1,366 shares during the last quarter. Franklin Resources Inc. grew its stake in Aveanna Healthcare by 4.5% in the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after purchasing an additional 1,528 shares in the last quarter. Olympiad Research LP increased its holdings in Aveanna Healthcare by 7.5% in the third quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock valued at $280,000 after buying an additional 2,200 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Aveanna Healthcare by 4.0% during the first quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock valued at $410,000 after buying an additional 2,918 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.